TRIB2 has previously been identified as an oncogene that causes acute myelogenous leukemia via inactivation of the transcription factor, CEBPA (CCAAT/enhancer-binding protein alpha) [15], [16]; however, to date there is no established relationship of TRIB2 with chemo-resistance. Here, CEBPA is linked to acute myeloid leukemia.